The Relationship between Maternal and Umbilical Cord Androgen Levels and Polycystic Ovary Syndrome in Adolescence: A Prospective Cohort Study
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
CONTEXT: The prenatal antecedents of polycystic ovary syndrome (PCOS) are not known, but prenatal androgen exposure is thought to contribute. This has not previously been investigated in large prospective studies of normal human pregnancy. OBJECTIVE: The aim of the study was to establish the prospective relationship between early life androgen exposure and PCOS in adolescence. DESIGN AND SETTING: A prospective cohort study was conducted in the general community. PATIENTS OR OTHER PARTICIPANTS: A total of 2900 pregnant women were recruited at 18 wk gestation. Prenatal androgen exposure was measured from maternal blood samples (at 18 and 34-36 wk) and umbilical cord blood. Timed (d 2-5 menstrual cycle) blood samples were collected, clinical hyperandrogenism was assessed, and transabdominal ultrasound examination of ovarian morphology was performed in 244 unselected girls from the Raine cohort aged 14-17 yr. MAIN OUTCOME MEASURE(S): We examined the relationship between early life androgen exposure and PCOS in adolescence. RESULTS: We did not observe a statistically significant relationship between early life androgen exposure and PCOS in adolescence. CONCLUSIONS: This is the first prospective study to evaluate the relationship between prenatal androgen exposure and PCOS in adolescence in normal pregnancy. Our findings do not support the hypothesis that maternal androgens, within the normal range for pregnancy, directly program PCOS in the offspring.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824 · cited 1×
“Concentrations of free testosterone were calculated (cFT) from the measured TT and SHBG concentrations using the Vermeulen equation (11).”
MethodAbbott, D. H., Barnett, D. K., Bruns, C. M., & Dumesic, D. A. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi013 · Cited by 555 · cited 1×
“congenital adrenal hyperplasia) suggests that excess fetal exposure to maternal androgens may induce the PCOS phenotype in offspring (5, 6).”
BackgroundChamberlain (2005) · doi:10.1016/j.neubiorev.2004.11.004 · Cited by 529
Menstrual cyclicity and the pre-menopause
Treloar, A. E. (1981) · Maturitas · doi:10.1016/0378-5122(81)90032-3 · Cited by 365 · cited 1×
“Irregular cycles were defined as those less than 25 or more than 35 d in duration or where the cycle length varied from month to month by more than 4 d (16).”
BackgroundNonclassical 21-Hydroxylase Deficiency
New, M. I. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1645 · Cited by 315
Thiboutot, D., Archer, D. F., Lemay, A., Washenik, K., Roberts, J., & Harrison, D. D. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01938-0 · Cited by 96
Cited by
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488
“Clinical studies have yet to confirm that testosterone excess during human fetal development promotes PCOS after birth”
BackgroundDumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020
Genetic, hormonal and metabolic aspects of PCOS: an update
De Leo, V., Musacchio, M. C., Cappelli, V., Massaro, M. G., Morgante, G., & Petraglia, F. (2016) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-016-0173-x · Cited by 484
“, showed no increase in T levels in umbilical cord blood of adolescent girls diagnosed with PCOS [17].”
BackgroundPoly Cystic Ovarian Syndrome: An Updated Overview
El Hayek, S., Bitar, L., Hamdar, L. H., Mirza, F. G., & Daoud, G. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00124 · Cited by 323
Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification
Dapas, M., & Dunaif, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac001 · Cited by 300
Sheep models of polycystic ovary syndrome phenotype
Padmanabhan, V., & Veiga-Lopez, A. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.10.005 · Cited by 225
“A recent study reported high levels of T in female offspring born to PCOS women (Barry et al., 2010), although other studies failed to do so (Anderson et al., 2010; Hickey et al., 2009).”
BackgroundResultNeuroendocrine dysfunction in polycystic ovary syndrome
Burt Solorzano, C. M., Beller, J. P., Abshire, M. Y., Collins, J. S., McCartney, C. R., & Marshall, J. C. (2012) · Steroids · doi:10.1016/j.steroids.2011.12.007 · Cited by 173
“A group of unselected adolescent girls showed no statistically significant relationship between maternal serum androgen levels during gestation and adolescent clinical hyperandrogenism or ovarian morphology [43].”
BackgroundHickey, M., Doherty, D. A., Atkinson, H., Sloboda, D. M., Franks, S., Norman, R. J., & Hart, R. (2011) · Human Reproduction · doi:10.1093/humrep/der102 · Cited by 170
Self-citationXu, N., Kwon, S., Abbott, D. H., Geller, D. H., Dumesic, D. A., Azziz, R., Guo, X., & Goodarzi, M. O. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027286 · Cited by 155
“Also, umbilical cord blood androgen levels were not found to be elevated in adolescent girls later diagnosed with PCOS [49], nor in one study were they elevated in the infant offspring of women with PCOS [50].”
BackgroundLifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause
Welt, C. K., & Carmina, E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2375 · Cited by 148
Polycystic ovarian morphology in postmenarchal adolescents
Codner, E., Villarroel, C., Eyzaguirre, F. C., López, P., Merino, P. M., Pérez-Bravo, F., Iñiguez, G., & Cassorla, F. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.06.015 · Cited by 113
“in healthy adolescents (16), but it is lower than the 54% prevalence observed by Mortensen et al.”
ResultMechanisms of intergenerational transmission of polycystic ovary syndrome
Dumesic, D. A., Hoyos, L. R., Chazenbalk, G. D., Naik, R., Padmanabhan, V., & Abbott, D. H. (2020) · Reproduction · doi:10.1530/rep-19-0197 · Cited by 101
Reproduction in females: The role of the early life environment
Sloboda, D. M., Hickey, M., & Hart, R. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq048 · Cited by 94
“and 15% using the NIH criteria (Hickey et al., 2009) and was associated”
BackgroundMethodInfluentialSelf-citationThe Polycystic Ovary Syndrome and recent human evolution
Corbett, S., & Morin-Papunen, L. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.01.001 · Cited by 68
Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood
Abbott, D. H., & Bacha, F. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.05.023 · Cited by 67
Polycystic ovary syndrome as a plausible evolutionary outcome of metabolic adaptation
Dumesic, D. A., Padmanabhan, V., Chazenbalk, G. D., & Abbott, D. H. (2022) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-021-00878-y · Cited by 63
“Maternal hyperandrogenemia from PCOS, however, may not directly program PCOS in offspring if placental aromatization is normal [93].”
BackgroundPrenatal Exposure to Endocrine Disruptors: A Developmental Etiology for Polycystic Ovary Syndrome
Hewlett, M., Chow, E., Aschengrau, A., & Mahalingaiah, S. (2017) · Reproductive Sciences · doi:10.1177/1933719116654992 · Cited by 61
Hyperinsulinaemic androgen excess in adolescent girls
Ibáñez, L., Ong, K. K., López-Bermejo, A., Dunger, D. B., & de Zegher, F. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.58 · Cited by 56
A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence
Merino, P. M., Codner, E., & Cassorla, F. (2011) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302011000800013 · Cited by 35
“A high prevalence of PCOM in healthy adolescents, with regular menstrual cycles and with no evidence of clinical hyperandrogenism, has been reported in the 30%-35% range (40-42), which is similar to the prevalence of 38% and 37% observed in adolescents with hyperandrogenism and or PCOS, respectively, but is lower comp…”
Result
Metadata
- Authors
- Hickey, M., Sloboda, D. M., Atkinson, H. C., Doherty, D. A., Franks, S., Norman, R. J., Newnham, J. P., & Hart, R.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2009-10-01
- Volume
- 94
- Issue
- 10
- Pages
- 3714-3720
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2089589494
- Cited by
- 142
- References
- 7
- FWCI
- 14.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.